Search Results

Annette worked in industry, academia and her entrepreneurial side led her to three companies, Cue Biotech

GPCR — Scaling Biotech Beyond the Bench Turning scientific excellence into scalable organizations. Our work helps biotech startups, research organizations, and CROs design operating systems that enable Bu Attila Foris 5 days ago The One Reason Why Biotech Startups Fail More Often Than They Should Biotech When complexity grows faster than strategy, biotech companies drift. Biotech fundraising has undergone a subtle yet significant shift.

Transform your biotech idea or data into a clear, strategic roadmap with aligned biology, timelines, Home About Services News Get in Touch Welcome Biotech Growth Wherever You Are in Discovery—Let’s Build Biotech teams often tell me: “We have too many CROs and not enough clarity.” How I Help Biotechs Accelerate GPCR Discovery with Clarity, Speed & Confidence Decisions, Not More Data updates that tie data to strategy Present clear next steps that build investor confidence Trusted by Biotech

GPCR Foundry is a nonprofit platform designed to help biotech leaders accelerate GPCR drug discovery Why Biotechs choose Dr. GPCR Foundry? The Foundry is built for GPCR biotech companies at the discovery stage . 🔬 Validate your first target Build credibility and visibility among scientists, biotechs, and CRO partners worldwide. with structured frameworks tailored for biotech growth.

When biotech partners trust your process, they come back again and again. Power My Discovery Biotech Clients Want Results - Not Confusion Every CRO I work with has great science—but Here's what I hear from biotech teams: “We’re not sure what we’re getting—or when we’re getting it.” How I Help CROs Deliver High-Impact Science That Biotech Teams Trust Biotech Clients Stay in Sync With What Matters We work together to position your CRO for growth • Refine your offering to match what biotech

GPCR Ecosystem: uniting scientists, biotech, and innovators to advance GPCR research worldwide. Who We Are We are a global network of scientists, biotech innovators, pharma professionals, CRO leaders & Get Our Weekly News See Why it Matters 6,600+ followers 200+ Research Labs 1,500+ Scientists 50+ Biotech Now, it's a global ecosystem of scientists, biotech teams, CRO leaders, and trainees working to move Premium Members Include: ✔ Drug hunters at early-stage biotechs ✔ CRO leaders building assays and tools

He is Chief Scientific Officer and co-founder of InterAx Biotech, where he specializes in the development Aurélien Rizk on the web InterAx Biotech Paul Scherrer Institut The Org LinkedIn Google Scholar Dr. Academia to Biotech: Strategic Planning and Interdisciplinary Approach Yamina Berchiche and Aurelien Rizk discussed the differences between academia and the biotech industry, with Aurelien Rizk sharing his experiences transitioning from academia into the biotech sector.

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics Ajay Yekkirala is a GPCR pharmacologist, biotech entrepreneur, and co-founder of Superluminal Medicines is the heart of scientific innovation Who Should Listen PhD students and postdocs exploring biotech careers GPCR scientists interested in translational innovation Biotech investors and strategic leaders seeking Ajay Yekkirala is a molecular pharmacologist, biotech founder, and scientist whose career has been defined

Building Z7 Biotech – The unexpected journey into biotech entrepreneurship, providing GPCR profiling services to pharma and biotech companies. In 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision Dmitry Veprintsev on the web LinkedIn Veprintsev Lab Z7 Biotech University of Nottingham Enjoying the

Stalled Pipeline Progression ❌ Uncertainty in GPCR Investments Advisory Focus Areas Expert support for Biotech innovators, VC investors and CRO partners Biotech Pipeline Acceleration For Biotech Leaders & Scientists Position: Showcase your specialized GPCR expertise to stand out from competitors and attract high-value biotech I integrate seamlessly with biotech, VC, and CRO teams as a trusted, objective partner. With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector

Dr GPCR University, creating more learning opportunities, and connecting scientists, students, and biotech Every contribution helps us bridge the gap between academia and biotech — transforming knowledge into connect scientists, founders, and innovators in a relaxed setting Job Board: helping researchers and biotech Help us close the gap between academia and biotech.

I developed G.CLIPS biotech's innovative technology as a synthesis of the different knowledge, experiences Before founding G.CLIPS biotech in June 2020. GPCR Ecosystem G.CLIPS Biotech on the web Website LinkedIn Enjoying the Dr. GPCR Podcast?

the University in Graz in Austria, Maria worked several years at Novo Nordisk before joining InterAx Biotech Maria Waldhoer on the web LinkedIn InterAx Biotech Pubmed Dr. GPCR Ecosystem Enjoying the Dr.

GPCR Retreat — an immersive event uniting scientists, biotech leaders, and innovators in GPCR research

Fast-track your biotech investments with VC Insights. Home About Services News Get in Touch Welcome VC Insights Fast Track Your Next Biotech Bet Get decision-grade talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today The Hidden Cost of Unclear Biotech Positioning How Early Strategic Decision Making Creates Alignment and Better Results Early Stage Biotech

How academia and biotech collaborate to scale GPCR tools—covering fluorescence assays, GPCR internalization GPCR Podcast , leaders from academia and biotech unpack what effective collaboration really looks like outperform antibodies for studying receptor localization and trafficking What changes when academia and biotech Maria Majellaro is the Chief Scientific Officer and co-founder of Celtarys Research , a biotech spin-off

After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer He has co-founded consultancy and biotech companies Svarlight and Antiverse.

Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the academic and biotech Personalised Therapeutics Technologies, Chief Scientific Advisor to Dimerix, and co-founder of RAGE Biotech

As a CRO partner, you'll gain trusted access to an engaged audience of biotech teams and drug discovery partner, you'll be featured across our nonprofit platform, trusted by thousands of GPCR scientists and biotech Social Media Promotion ✓ Engaging posts about your organization ✓ Targeted to GPCR researchers and biotech

GPCR was created to break down barriers across academia, biotech, pharma, and CROs—so knowledge, tools field , including: Academic researchers (PI, postdoc, student) Industry scientists and R&D leaders Biotech

talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

As a media partner, you'll gain trusted access to an engaged audience of academic researchers, biotech partner, you'll be featured across our nonprofit platform, trusted by thousands of GPCR scientists and biotech Social Media Promotion ✓ Engaging posts about your organization ✓ Targeted to GPCR researchers and biotech

Frequently asked questions University Vault Premium Pricing GPCR Masterclass YC-Biotech YC-VC YC-CRO

CSO of Celtarys Research, shares the story behind the company’s journey from academic curiosity to biotech When the time came to decide whether to leave the lab and lead Celtarys into biotech, she took the leap Like many scientists-turned-entrepreneurs, Maria faced the challenge of learning the business side of biotech That changed with support from Galicia’s robust biotech network, and the company quickly defined its

GPCR Ecosystem, with the goal is to bring together GPCR scientists, biotech, and pharma leaders as well

Inoviem scientific in Nov. 2011 by myself we have been regularly working with GPCRs for our pharma and biotech

More broadly, I hope to be a critical contributor to a growing Canadian biotech sector in both scientific

Vibrio fischeri also induces mating in S. rosetta cultures, suggesting that multiple environmental cues

As an industry pharmacologist, he consults with numerous pharma and biotechs in understanding and applying